Skip Links

  • Go to homepage [Accesskey '0']
  • Go to content [Accesskey '1']
  • Go to navigation [Accesskey '2']
  • Search site [Accesskey '3']
  • Go to footer links [Accesskey '4']
  • Go to accessibility page [Accesskey '5']
  • About us
  • Patients & carers
  • Health professionals
  • Investors
  • Media Center
  • Contact us
  • Home
  • >
  • Patients & carers
  • >
  • Pediatric OCD
  • >
  • FAQ
Neuropharm

Patients & carers

  • Autism
  • Fragile X syndrome
  • Pediatric OCD
    • FAQ

Pediatric OCD

FAQs

  • Q1 What is Obsessive Compulsive Disorder (OCD)?
  • Q2 How common is OCD?
  • Q3 What are the characteristics of OCD?
  • Q4 How does OCD impact on carers, friends and family?
  • Q5 What is NPL-2003?
  • Q6 Where and when will NPL-2003 be made available to patients?
  • Q7 Can my child take part in clinical trials for NPL-2003?

Q7 Can my child take part in clinical trials for NPL-2003?

For more information on participating in clinical trials, please see www.clinicaltrials.gov.

Back to top

Related links

  • Portfolio and pipeline Find out more about our Pediatric OCD program
  • Key relationships Our important collaborations

Contact us

  • UK office

Neuropharm Group plc
Fetcham Park House
Lower Road
Leatherhead
Surrey KT22 9HD
United Kingdom

T: +44 (0)1372 371 171

Email: UK office

Site by Radley Yeldar

© Neuropharm Group plc 2010

  • Sitemap
  • Privacy policy
  • Accessibility
  • Useful links
  • Glossary
  • Careers